On September 1, 2025, the 3rd Greater Bay Area Pharmaceutical Industry Manufacturing 4.0 Forum was successfully held at the Shenzhen Convention and Exhibition Center. The forum brought together top industry experts and corporate representatives to discuss the application and innovation of smart manufacturing technologies in the pharmaceutical industry. Mr. Wei Qingkun, Vice President of Canton Biologics, was invited to attend and delivered a keynote speech titled “Application of Smart Manufacturing 4.0 in Biopharmaceuticals,” sharing his insights on the intelligent transformation of biologics manufacturing.

On May 21, the conference “Financial Empowerment for High‑Quality Development of Biomedical Enterprises in the Greater Bay Area” was successfully held at the Hampton by Hilton Guangzhou Tianhe Pearl New City. The event was hosted by the Guangzhou Branch of China Everbright Bank Co., Ltd., organized by Guangzhou Canton Biologics Technology Co., Ltd., and supported by the Guangzhou‑Hong Kong‑Macao High‑level Talent Achievement Transformation Promotion Association. The conference brought together representatives from government funds, financial institutions, biopharmaceutical companies, and research institutes to engage in in‑depth discussions on policy support for the biomedical industry in the Greater Bay Area (GBA), pathways for financial empowerment, and full‑chain biopharmaceutical services in the region.

2024年11月11日，汉腾生物在广州参加了由中山大学主办的“中山大学生物医药产业联盟论坛”。本次论坛汇聚了生物医药领域的顶尖专家和中山大学的优秀硕博士人...

With the theme "Cross-Regional Collaboration, Jointly Promoting Translation," this forum aims to bring together leading experts from academia, industry, and the investment community to discuss cutting-edge advances and collaborative strategies in the field of biotherapeutics. By fostering multi-stakeholder dialogue, the forum will strive to build a bridge between academic innovation and commercial translation, advancing science-driven, patient-centered development of innovative therapies in biomedicine.

On January 5–6, 2024, Professor Liu Yuanshuai from the Hong Kong University of Science and Technology (HKUST) led more than 40 faculty members and students from the Department of Chemical and Biological Engineering to visit Canton Biologics. Mr. Zhang Chunhua, Vice President of Canton Biologics, welcomed the delegation on behalf of the company’s senior management team and delivered an opening address. This visit marked another in‑depth collaborative interaction and discussion between the two sides, following a special seminar given by Dr. Shen Xiao, CEO of Canton Biologics, at HKUST in October 2023.

On March 21, the upgrade ceremony of Canton Biologics’ Foshan Kunlun commercial manufacturing base was successfully held at the Foshan Kehui Life Science and Technology Industrial Center. Leaders and guests from various functional bureaus of Foshan City, districts, and towns, as well as important partners of Canton Biologics, shareholder representatives, bankers, and media friends, attended the event to witness this milestone moment.

On December 21, 2023, the award ceremony for the fifth batch of National "Little Giant" Enterprises, organized by the Ministry of Industry and Information Technology, concluded successfully.